- Home
- RSSS vs BCAB Comparison
RSSS vs BCAB Comparison
Compare RSSS & BCAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSSS
- BCAB
- Stock Information
- Founded
- RSSS 2006
- BCAB 2007
- Country
- RSSS United States
- BCAB United States
- Employees
- RSSS N/A
- BCAB N/A
- Industry
- RSSS Business Services
- BCAB Medicinal Chemicals and Botanical Products
- Sector
- RSSS Consumer Discretionary
- BCAB Health Care
- Exchange
- RSSS Nasdaq
- BCAB Nasdaq
- Market Cap
- RSSS 86.4M
- BCAB 96.2M
- IPO Year
- RSSS N/A
- BCAB 2020
- Fundamental
- Price
- RSSS $2.68
- BCAB $2.08
- Analyst Decision
- RSSS Strong Buy
- BCAB Strong Buy
- Analyst Count
- RSSS 1
- BCAB 2
- Target Price
- RSSS $6.00
- BCAB $6.00
- AVG Volume (30 Days)
- RSSS 30.4K
- BCAB 1.6M
- Earning Date
- RSSS 11-07-2024
- BCAB 11-08-2024
- Dividend Yield
- RSSS N/A
- BCAB N/A
- EPS Growth
- RSSS N/A
- BCAB N/A
- EPS
- RSSS N/A
- BCAB N/A
- Revenue
- RSSS $44,623,899.00
- BCAB N/A
- Revenue This Year
- RSSS $13.76
- BCAB N/A
- Revenue Next Year
- RSSS $9.92
- BCAB N/A
- P/E Ratio
- RSSS N/A
- BCAB N/A
- Revenue Growth
- RSSS 18.35
- BCAB N/A
- 52 Week Low
- RSSS $2.21
- BCAB $1.14
- 52 Week High
- RSSS $3.50
- BCAB $4.02
- Technical
- Relative Strength Index (RSI)
- RSSS 50.43
- BCAB 55.80
- Support Level
- RSSS $2.55
- BCAB $1.87
- Resistance Level
- RSSS $2.75
- BCAB $2.13
- Average True Range (ATR)
- RSSS 0.10
- BCAB 0.12
- MACD
- RSSS -0.00
- BCAB 0.00
- Stochastic Oscillator
- RSSS 53.57
- BCAB 68.90
About RSSS Research Solutions Inc
Research Solutions Inc is a holding company. The company provides a cloud-based SaaS research intelligence platform consisting of proprietary software and Internet-based interfaces. Its platform also allows customers to find and download digital versions of STM articles. Platforms and Transactions are packaged as a single solution that enables life science and other research-intensive organizations to speed up research and development activities. The company platform allows customers to initiate orders, manage transactions, automate authentication, obtain reports, and connect seamlessly to corporate intranets.
About BCAB BioAtla Inc.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.